Cointime

ArgiNOx Phamaceuticals

company

About

Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies.

  • 11 - 50

Highlights

Total Funding Amount
$33M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$8M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for the treatment of cardiogenic shocks. Arginox Pharmaceuticals is based in Redwood City, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$33M
ArgiNOx Phamaceuticals has raised a total of $33M in funding over 2 rounds. Their latest funding was raised on Mar 2, 2005 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 2, 2005 Series C $25M 1 — — Detail
Jun 12, 2004 Series B $8M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
ArgiNOx Phamaceuticals is funded by 1 investors. Perseus-Soros Biopharmaceutical Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Perseus-Soros Biopharmaceutical Fund — Series C
Cointime
เนื้อหา
บริษัท